B cells in multiple sclerosis - from targeted depletion to immune reconstitution therapies

Nat Rev Neurol. 2021 Jul;17(7):399-414. doi: 10.1038/s41582-021-00498-5. Epub 2021 Jun 1.


Increasing evidence indicates the involvement of B cells in the pathogenesis of multiple sclerosis (MS), but their precise roles are unclear. In this Review, we provide an overview of the development and physiological functions of B cells and the main mechanisms through which B cells are thought to contribute to CNS autoimmunity. In MS, abnormalities of B cell function include pro-inflammatory cytokine production, defective B cell regulatory function and the formation of tertiary lymphoid-like structures in the CNS, which are the likely source of abnormal immunoglobulin production detectable in the cerebrospinal fluid. We also consider the hypothesis that Epstein-Barr virus (EBV) is involved in the B cell overactivation that leads to inflammatory injury to the CNS in MS. We also review the immunological effects - with a focus on the effects on B cell subsets - of several successful therapeutic approaches in MS, including agents that selectively deplete B cells (rituximab, ocrelizumab and ofatumumab), agents that less specifically deplete lymphocytes (alemtuzumab and cladribine) and autologous haematopoietic stem cell transplantation, in which the immune system is unselectively ablated and reconstituted. We consider the insights that these effects on B cell populations provide and their potential to further our understanding and targeting of B cells in MS.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • B-Lymphocytes / drug effects
  • B-Lymphocytes / immunology*
  • Clinical Trials as Topic / methods
  • Drug Delivery Systems / methods
  • Drug Delivery Systems / trends*
  • Humans
  • Immune Reconstitution / immunology*
  • Immunologic Factors / administration & dosage
  • Immunotherapy / methods
  • Immunotherapy / trends*
  • Multiple Sclerosis / immunology*
  • Multiple Sclerosis / therapy*


  • Immunologic Factors